Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives

Lo.Li.Pharma

Status: Withdrawn

Conditions: Contraception

Treatments: Dietary Supplement: Zyxelle; Drug: Oral contraceptive

Study type: Interventional

Funder types: Industry

Identifiers

NCT07071389

000152

Details and patient eligibility

About

Prospective, controlled study. Administration of a specifically formulated supplement to women prescribed oral contraceptives. Evaluation of: a) reduction of adverse effects of the treatment; b) improvement of patients' quality of life.

Sex: Female

Ages: 18 to 39 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Body Mass Index: 18-30 Kg/m2;
2. Prescription for COC treatment

Exclusion criteria

1. diabetes;
2. previous or existing breast pathologies;
3. hypertension;
4. obesity;
5. smoking habits;
6. cardiovascular disorders

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Control group

Active Comparator group

Description:

Patients prescribed estroprogestinic oral contraceptive

Treatment:

Drug: Oral contraceptive

Study group

Experimental group

Description:

Patients prescribed estroprogestinic oral contraceptive were treatedwith Zyxelle supplement

Treatment:

Drug: Oral contraceptive

Dietary Supplement: Zyxelle